Malignant obstruction palliative nephrostomy demand — the long-term indwelling percutaneous nephrostomy tubes and nephroureteral stents creating urinary diversion for irresectable pelvic malignancies with expected survival of six months to two years representing the most chronic care-focused segment in the global nephrostomy devices market — creates the most palliative care-oriented...